India to United States: Glimepiride Export Trade Route
India has recorded 156 verified shipments of Glimepiride exported to United States, representing a combined trade value of $50.2M USD. This corridor is served by 6 active Indian exporters, with an average shipment value of $321.6K USD. The leading Indian exporter is INDOCO REMEDIES LIMITED, which accounts for 92% of total export value with 31 shipments worth $46.0M USD. On the buying side, NA is the largest importer in United States with $46.0M USD in purchases. The top 3 suppliers — INDOCO REMEDIES LIMITED, MICRO LABS LIMITED, DR REDDYS LABORATORIES LIMITED — together control 99% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Glimepiride corridor is one of India's established pharmaceutical export routes, with 156 shipments documented worth a combined $50.2M USD. The route is dominated by INDOCO REMEDIES LIMITED, which alone accounts for roughly 92% of all export value, reflecting the consolidated nature of India's glimepiride manufacturing sector.
Across 6 active suppliers, the average shipment value stands at $321.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 22.3%, placing it at rank #15 among India's top glimepiride export destinations globally.
On the import side, key buyers of Indian glimepiride in United States include NA, EVERSANA LIFE SCIENCE SERVICES, LLC, EVERSANA LIFE SCIENCE SERVICES LLC and 8 others. NA is the single largest importer with 31 shipments valued at $46.0M USD.
Route Characteristics
- Average transit18 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portJNPT/ NHAVA SHEVA SEA
Market Position
- Global rank#15
- Annual growth+22.3%
- Demand growth+20.7%
- Regulatory ease68/100
Top 10 Indian Glimepiride Exporters to United States
Showing top 10 of 6 Indian suppliers exporting Glimepiride to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INDOCO REMEDIES LIMITED Avg $1.5M per shipment | 31 | $46.0M | 91.7% |
| 2 | MICRO LABS LIMITED Avg $25.5K per shipment | 111 | $2.8M | 5.6% |
| 3 | DR REDDYS LABORATORIES LIMITED Avg $116.1K per shipment | 6 | $696.6K | 1.4% |
| 4 | DR REDDY S LABORATORIES LIMITED Avg $189.2K per shipment | 2 | $378.5K | 0.8% |
| 5 | MICRO LABS LTD Avg $46.5K per shipment | 5 | $232.7K | 0.5% |
| 6 | NV LIFESCIENCE Avg $342 per shipment | 1 | $342 | 0.0% |
This table shows the top 10 of 6 Indian companies exporting glimepiride to United States, ranked by total trade value. The listed exporters are: INDOCO REMEDIES LIMITED, MICRO LABS LIMITED, DR REDDYS LABORATORIES LIMITED, DR REDDY S LABORATORIES LIMITED, MICRO LABS LTD, NV LIFESCIENCE. INDOCO REMEDIES LIMITED is the dominant supplier with 31 shipments worth $46.0M USD, giving it a 92% market share. The top 3 suppliers together account for 99% of the total trade value on this route.
Top 10 Glimepiride Importers in United States
Showing top 10 of 11 known buyers in United States receiving Glimepiride shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian glimepiride in United States include NA, EVERSANA LIFE SCIENCE SERVICES, LLC, EVERSANA LIFE SCIENCE SERVICES LLC, AMERISOURCE HEALTH SERVICES, DR REDDYS LABORATORIES INC, among 11 total buyers. The largest importer is NA, accounting for $46.0M USD across 31 shipments — representing 92% of all glimepiride imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NA | 31 | $46.0M | 91.7% |
| 2 | EVERSANA LIFE SCIENCE SERVICES, LLC | 43 | $939.5K | 1.9% |
| 3 | EVERSANA LIFE SCIENCE SERVICES LLC | 25 | $905.2K | 1.8% |
| 4 | AMERISOURCE HEALTH SERVICES | 38 | $704.6K | 1.4% |
| 5 | DR REDDYS LABORATORIES INC | 6 | $696.6K | 1.4% |
| 6 | XX REXXYS XXBORXXORIXX INXX | 1 | $334.2K | 0.7% |
| 7 | EVERSANA LIFE SCIENCE SERVICES | 8 | $312.0K | 0.6% |
| 8 | WELLGISTICS | 1 | $147.5K | 0.3% |
| 9 | EVERSANA LIFE SCIENCE SERVICES,LLC. | 1 | $58.2K | 0.1% |
| 10 | XX REXXY SXXABOXXTORXXS IXX | 1 | $44.3K | 0.1% |
Showing top 10 of 11 Glimepiride importers in United States on this route.
Top 10 Glimepiride Formulations Imported by United States
Showing top 10 of 112 product formulations shipped on the India to United States Glimepiride route, ranked by trade value
United States imports a wide range of glimepiride formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — GLIMEPIRIDE TABLETS 4MG, PACK OF 500 (EACH UNCOATED TABLETS CONTAINS GLIMEPIRIDEUSP 4MG) — accounts for $19.5M USD across 1 shipments. There are 112 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GLIMEPIRIDE TABLETS 4MG, PACK OF 500 (EACH UNCOATED TABLETS CONTAINS GLIMEPIRIDEUSP 4MG) | 1 | $19.5M | 39.0% |
| 2 | GLIMEPIRIDE TABLETS 2MG, PACK OF 500 (EACH UNCOATED TABLETS CONTAINS GLIMEPIRIDEUSP 2MG) | 1 | $15.7M | 31.2% |
| 3 | GLIMEPIRIDE TABLETS 1MG, PACKS OF 500 (EACH UNCOATED TABLETS CONTAINS GLIMEPIRIDE USP 1MG) | 1 | $5.2M | 10.4% |
| 4 | GLIMEPIRIDE TABLETS 4MG, PACK OF 100 (EACH UNCOATED TABLETS CONTAINS GLIMEPIRIDEUSP 4MG) | 1 | $2.6M | 5.3% |
| 5 | GLIMEPIRIDE TABLETS 2MG, PACK OF 100 (EACH UNCOATED TABLETS CONTAINS GLIMEPIRIDEUSP 2MG) | 1 | $2.2M | 4.4% |
| 6 | GLIMEPIRIDE TABLETS 4MG (500'S PACK) | 1 | $334.2K | 0.7% |
| 7 | GLIMEPIRIDE TABLETS 4MG 500'S PACK | 1 | $334.1K | 0.7% |
| 8 | GLIMEPIRIDE TABLETS USP 4mg ( 1X100'S ) ( QTY- 93564.000 ) | 2 | $237.0K | 0.5% |
| 9 | GLIMEPIRIDE TABLETS 2MG 100'S PACK | 2 | $180.6K | 0.4% |
| 10 | GLIMEPIRIDE TABLETS USP 4 MG ANDA NO 091 220 NDC NO 42571 103 01 PACK 1X100S TAX INV NO 706204451 | 2 | $170.9K | 0.3% |
Showing top 10 of 112 Glimepiride formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 67% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
JNPT/ NHAVA SHEVA SEA handles the highest volume with 50 shipments. Transit time averages 18 days by sea.
Market Dynamics
India's glimepiride exports to United States are driven primarily by a handful of large-scale manufacturers. INDOCO REMEDIES LIMITED with 31 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — INDOCO REMEDIES LIMITED, MICRO LABS LIMITED, DR REDDYS LABORATORIES LIMITED — together account for 99% of total trade value on this route. The average shipment value of $321.6K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as glimepiride tablets 2mg, pack of 500 (each uncoated tablets contains glimepirideusp 2mg) and glimepiride tablets 1mg, packs of 500 (each uncoated tablets contains glimepiride usp 1mg), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, NA is the largest importer with 31 shipments worth $46.0M USD — representing 92% of all glimepiride imports from India on this route. A total of 11 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $50.2M
- Avg. Shipment
- $321.6K
- Suppliers
- 6
- Buyers
- 11
- Transit (Sea)
- ~18 days
- Annual Growth
- +22.3%
Related Analysis
Reverse Direction
United States → India — Glimepiride (Import)Other Glimepiride Routes
Glimepiride — Export Intelligence Video
Visual overview of India's glimepiride India to United States export trade route — top suppliers, destinations, pricing, and trade routes
Unlock the Full India to United States Glimepiride Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 156 shipments on this route.
Frequently Asked Questions — India to United States Glimepiride Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Glimepiride to United States?
The leading Indian exporters of Glimepiride to United States are INDOCO REMEDIES LIMITED, MICRO LABS LIMITED, DR REDDYS LABORATORIES LIMITED. INDOCO REMEDIES LIMITED holds the largest market share at approximately 92% of total trade value on this route.
Q What is the total value of Glimepiride exports from India to United States?
India exports Glimepiride to United States worth approximately $50.2M USD across 156 recorded shipments. The average value per shipment is $321.6K USD.
Q Which ports does India use to ship Glimepiride to United States?
The most active port of origin is JNPT/ NHAVA SHEVA SEA with 50 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 67% of shipments going by sea and 17% by air.
Q How long does shipping take from India to United States for Glimepiride?
The average transit time for Glimepiride shipments from India to United States is approximately 18 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United States Glimepiride trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 22.3% with demand growth tracking at 20.7%. The route is ranked #15 among India's top Glimepiride export destinations globally.
Q How many suppliers are active on the India to United States Glimepiride route?
There are currently 6 active Indian suppliers exporting Glimepiride to United States. The market is moderately concentrated with INDOCO REMEDIES LIMITED accounting for 92% of total shipment value.
Q Who are the main importers of Glimepiride from India in United States?
The leading importers of Indian Glimepiride in United States include NA, EVERSANA LIFE SCIENCE SERVICES, LLC, EVERSANA LIFE SCIENCE SERVICES LLC, AMERISOURCE HEALTH SERVICES, DR REDDYS LABORATORIES INC. NA is the largest buyer with 31 shipments worth $46.0M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Glimepiride.
- 2.Supplier/Buyer Matching: 6 Indian exporters and 11 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 156 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
156 Verified Shipments
6 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists